Jennifer Gilbert

Jennifer Gilbert is a Portfolio Strategy Leader in Early Research and Discovery at Roche, a major pharmaceutical company. Based on the available information:

Professional Background

• Jennifer currently works at Roche in a leadership role focused on portfolio strategy for early-stage research and drug discovery.1

• She has expertise in healthcare strategy, particularly in areas like research and development, supply chain, and portfolio management.

• Prior to Roche, Jennifer worked as a strategy consultant at PwC, specializing in healthcare with 7 years of experience.

Education

Jennifer holds an advanced degree from Yale School of Management, likely an MBA given her career path in business strategy.1

Areas of Focus

• Vaccine portfolio strategy: Jennifer has shared insights on developing competitive vaccine portfolios, indicating her involvement in this area at Roche.2

• Early-stage research: Her current role focuses on strategy for early research and discovery phases of drug development.1

• Healthcare industry expertise: She has broad experience across R&D, supply chain, and other aspects of the pharmaceutical/healthcare sector.

Professional Network

Jennifer appears to be well-connected in her industry, with over 500 connections on LinkedIn.1 This suggests she is an established professional in the pharmaceutical and healthcare strategy space.

While more detailed information about her specific responsibilities or achievements at Roche is not available, her background and current role indicate she plays a significant part in shaping Roche's early-stage research strategy and portfolio decisions.